Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|July 5, 2014
Reducing neck incision length during thyroid surgery does not improve satisfaction in patientsSeok-Mo Kim, Ki Won Chun, Ho Jin Chang, et al.
Journal of Structural Biology|November 25, 2010
Structural basis of triclosan resistanceN Jiten Singh, Dongkyu Shin, Han Myoung Lee, et al.
International Journal of Molecular Sciences|January 12, 2021
Synergistic Anticancer Activity of <i>N</i>-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer ModelsHyeok Jun Yun, Hee Jun Kim, Jungmin Kim, et al.
ANZ Journal of Surgery|July 2, 2014
Tuberculosis cervical lymphadenopathy mimics lateral neck metastasis from papillary thyroid carcinomaSeok-Mo Kim, Hak Hoon Jun, Ho-Jin Chang, et al.
BMC Cancer|October 6, 2018
SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid CancerSoo Young Kim, Seok-Mo Kim, Ho-Jin Chang, et al.
Thyroid : Official Journal of the American Thyroid Association|April 24, 2015
Recovery from Permanent Hypoparathyroidism After Total ThyroidectomySeok-Mo Kim, Hyeung Kyoo Kim, Kuk-Jin Kim, et al.
Head & Neck|October 21, 2014
Thyroidectomy without lateral neck dissection for papillary thyroid carcinoma with lateral neck lymph node metastases and negative intraoperative frozen sectionSeok-Mo Kim, Hyeung Kyoo Kim, Kuk-Jin Kim, et al.
Neoplasia (New York, N.Y.)|January 15, 2018
Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem CellsYong Sang Lee, Seok-Mo Kim, Bup-Woo Kim, et al.
The Journal of Biological Chemistry|May 4, 2011
Molecular mechanism of activation of human Cdc7 kinase: bipartite interaction with Dbf4/activator of S phase kinase (ASK) activation subunit stimulates ATP binding and substrate recognitionRyo Kitamura, Rino Fukatsu, Naoko Kakusho, et al.
Bioorganic & Medicinal Chemistry Letters|June 8, 2012
Design, synthesis and biological evaluation of novel imidazopyridines as potential antidiabetic GSK3β inhibitorsSeung-Chul Lee, Hyun Tae Kim, Choul-Hong Park, et al.
Pageof 3